Recent developments in human immunodeficiency virus-1 latency research.

Chi Ngai Chan, Isabelle Dietrich, Margaret J Hosie, Brian J Willett

Journal: The Journal of general virology 2013;94(Pt 5):917-932

PMID: 23364195

Abstract

Almost 30 years after its initial discovery, infection with the human immunodeficiency virus-1 (HIV-1) remains incurable and the virus persists due to reservoirs of latently infected CD4(+) memory T-cells and sanctuary sites within the infected individual where drug penetration is poor. Reactivating latent viruses has been a key strategy to completely eliminate the virus from the host, but many difficulties and unanswered questions remain. In this review, the latest developments in HIV-persistence and latency research are presented.

Address: MRC-University of Glasgow Centre for Virus Research, Bearsden Road, Glasgow G61 1QH, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.